ChemGenex's omacetaxine may provide first viable treatment option for highly resistant form of CML
... MELBOURNE, Australia, and MENLO PARK, California U.S.A. (June 1st, 2009) chemgenex
Pharmaceuticals Limited (ChemGenex) (ASX:CXS) announced that the latest data from its pivotal study of omacetaxine in patients with T315I-positive chr...
Arete Therapeutics Appoints Donald Santel to Board of Directors
...quired by Boston Scientific. Mr. Santel
began his career at Medtronic, Inc. Currently, Mr. Santel also serves on
the board of Anthera Pharmaceuticals, chemgenex
Hyperion Therapeutics. He has a BSE from Purdue University and an MS in
from the University of Minnesota.
About Arete Therapeut...
ChemGenex Treats First Patient With Ceflatonin
... Melbourne-based chemgenex
Pharmaceuticals has treated the first patient in a new phase II/III clinica...rolled into CML-203 at the MD Anderson Cancer Center in Houston, Texas, and chemgenex
is expanding the study to an estimated 15 centers through the United States...
Scientists Hopeful of a Cure for Diabetes
...s has long been considered as a lifestyle disease linked to a poor dietary habits and sedentary lifestyle.
The gene was unearthed by the chemgenex
Pharmaceuticals team from Geelong providing scientists worldwide with the much-needed impetus to develop new tests and drugs for diabetes.
Genetics helps in attacking cancer
... genes, which may help refine future treatments. Ceflatonin, a natural product, is being tested as an anti-cancer treatment. Meanwhile, the US company chemgenex
is looking at the effect of the drug on the genes that are activated in cancer. They find that specific genes and cellular pathways are affected by ce...